Glaxosmithkline is extending its product portfolio in the Middle East. The company has acquired the branded generics business of Bristol-Myers Squibb in Lebanon, Jordan, Syria, Libya and Yemen for a cash consideration of $23.2 million.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
